Mesa Laboratories Inc /CO MLAB

FY2026 · ended Mar 31, 2026 · Revenue $249.13M, +3.4% YoY · Filed Jun 3, 2026

Mesa Laboratories Inc /CO (MLAB) files with the SEC under industry code 3823, Industrial Instruments For Measurement, Display, and Control. In fiscal 2026, which ended Mar 31, 2026, it reported revenue of $249.1 million and net income of $6.7 million. Free cash flow was $39.6 million. As of Jun 30, 2026 it held $30.7 million in cash and investments and $84.6 million in total debt.

Revenue
$249.13M
+3.4% vs prior year
Net income
$6.71M
+440.0% vs prior year
Operating cash flow
$42.83M
-8.5% vs prior year
Free cash flow
$39.58M
-7.0% vs prior year
EPS
$1.21
+436.1% vs prior year
Dividend per share
$0.64
+0.0% vs prior year
Shares outstanding
5.52M
+1.3% vs prior year
Net cash
$-53.88M
as of Jun 30, 2026
Operating margin
7.4%
FY 2026

Company profile

Industry
Industrial Instruments For Measurement, Display, and Control (SIC 3823)
Listed as
MLAB (Nasdaq)
Fiscal year ends
March 31
Incorporated in
CO
Headquarters
Lakewood, CO
SEC filer status
Accelerated filer
SEC CIK
724004
Former names
MESA LABORATORIES INC /CO (until Aug 28, 2020)

Other Industrial Instruments For Measurement, Display, and Control companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2026
Mar 31, 2026
FY 2025
Mar 31, 2025
FY 2024
Mar 31, 2024
FY 2023
Mar 31, 2023
FY 2022
Mar 31, 2022
Revenue
$249.1M
$241.0M
$216.2M
$219.1M
$184.3M
Operating income
$18.5M
$16.3M
-$272.1M
$3.3M
$4.7M
Net income
$6.7M
-$2.0M
-$254.2M
$930,000
—
Diluted EPS
$1.21
-$0.36
-$47.20
$0.17
$0.35
Operating cash flow
$42.8M
$46.8M
$44.1M
$28.0M
$39.2M
Free cash flow
$39.6M
$42.6M
$41.6M
$23.4M
$34.8M
Total assets
$427.7M
$433.3M
$446.8M
$661.8M
$707.4M
Total liabilities
$241.5M
$273.5M
$301.4M
$268.4M
$313.6M
Stockholders' equity
$186.2M
$159.8M
$145.4M
$393.5M
$393.8M
Cash and investments
$26.9M
$27.3M
$28.2M
$32.9M
$49.3M
Total debt
$84.8M
$87.2M
$9.6M
$8.6M
$10.2M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Exit or restructuring costs, Regulation FD disclosure
Oct 13, 2026 Oct 12, 2026
8-K Current report
Shareholder vote results
Sep 8, 2026 Sep 8, 2026
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
8-K Current report Jul 30, 2026 Jul 30, 2026
8-K Current report
Officer or director change
Jun 15, 2026 Jun 11, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.